• Lilly hails Alzheimer's win with donanemab, boasting 'significant slowing of decline'

    11 days ago - By Fierce Biotech

    Lilly hails Alzheimer's win with donanemab, boasting 'significant slowing of decline' badams
    Mon, 01/11/2021 - 07:11
    Read more ...

     

  • JPM: Biogen bullish on Alzheimer's drug approval, sees Lilly data as a positive, despite AdComm rejection

    11 days ago - By Fierce Biotech

    JPM: Biogen bullish on Alzheimer's drug approval, sees Lilly data as a positive, despite AdComm rejection badams
    Mon, 01/11/2021 - 11:17
    Read more ...